Green chatter on quarterly calls peaked at the beginning of 2022, months before passage of then-President Joe Biden’s ...
Humacyte Inc. (NASDAQ: HUMA) reported its fourth-quarter 2024 earnings, revealing a narrower-than-expected loss per share (EPS) of $0.16 compared to the forecasted loss of $0.25. The announcement ...
Operator: Good morning and thank you for standing by. Currently, all the participants are in a listen-only mode. After ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback